Novavax | NVAX - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Adma Biologics USD 114.5M 24.66M 2026-03
Agenus USD 33.7M 500K 2026-03
AstraZeneca USD 15.38B 90M 2026-06
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Geron USD 57.48M 5.64M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
MannKind USD 90.2M 21.76M 2026-03
Merck USD 16.6B 310M 2026-06
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 100M 289M 2026-06
Novartis USD 13.11B 750M 2026-03
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 15.03B 530M 2026-06
Sanofi EUR 11.95B 710M 2026-06
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
TG Therapeutics USD 240.34M 45.54M 2026-06